Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Multiple sclerosis+2

Not recruiting

Registered drug

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

Registered drug

Spain

Participants:18–64 years
Substances:Methylprednisolone

Contact Research Centre

Prostate cancer recurrent

Not recruiting

Registered drugNo placebo

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Migraine+1

Not recruiting

Registered drugNo placebo

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Eptinezumab

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Investigational

Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Axatilimab

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

InvestigationalNo placebo

Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Selpercatinib

Contact Research Centre

Sepsis+1

Not recruiting

Registered drug

Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Terlipressin Acetate

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Spain

Participants:18–64 years
Substances:Charcoal, Activated

Contact Research Centre

Ulcerative keratitis

Not recruiting

InvestigationalNo placebo

Study on Allogenic Stem Cells and Amniotic Membrane for Patients with Advanced Corneal Ulcers Unresponsive to Standard Treatment

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Allogenic Corneal-Derived Adult Keratocytes, Ex-Vivo Expanded

Contact Research Centre

Find therapies in clinical trials near you – page 6

83 trials match your criteria

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Multiple sclerosis+2

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

Prostate cancer recurrent

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Migraine+1

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Idiopathic pulmonary fibrosis

Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

Non-small cell lung cancer

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Sepsis+1

Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Bladder transitional cell carcinoma

Study of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy

Relapsing multiple sclerosis

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Ulcerative keratitis

Study on Allogenic Stem Cells and Amniotic Membrane for Patients with Advanced Corneal Ulcers Unresponsive to Standard Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.